Patent · US Active

Bispecific binding proteins and uses thereof

US11279759B2 · kind B2 · utility

1Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 13, 2019
Grant dateMar 22, 2022
Priority date
Expiry dateFeb 19, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure generally provides proteins that bind two epitopes (e.g., a first and a second epitope) and that are bivalent for binding to each of the first and second epitopes. The disclosure also provides for specific binding proteins, including antibodies, which bind to a target protein. The disclosure also provides compositions comprising such proteins, nucleic acid molecules encoding such proteins and methods of making such proteins. The disclosure provides methods of inducing an immune response in a subject as well as methods for treating or preventing cancer in a subject by administering the proteins, nucleic acid molecules and/or compositions to the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.